Microdosing Standard therapeutic doses (semaglutide 1.02.4mg/week, tirzepatide 515mg/week) are designed for significant weight loss in people who do not train intensely
Some people experience digestive side effects when using GLP-1 agonists, such as nausea, vomiting, diarrhea, feelings of early fullness, reduced appetite, and abdominal cramps
Weekly Injection Administration The injections are administered once per week, typically in the abdomen, thigh, or upper arm
Without ample aminos, which your body doesnt produce on its own, you cant properly synthesize and digest proteinan essential macronutrient for fitness (and much more)
Studies show the peptide stimulates secretion of vascular endothelial growth factor (VEGF) and hepatocyte growth factor (HGF) from hair follicle cells, with experimental formulations producing the most significant increases in these growth factors